Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

133

Full text

111

Free full text

Publication Types

Journal Article

140

Observational Study

Research Support, Non-U.S. Gov't

Review

Multicenter Study

Clinical Trial

Comparative Study

Randomized Controlled Trial

Meta-Analysis

Systematic Review

Clinical Trial, Phase IV

Case Reports

Evaluation Study

Comment

Research Support, U.S. Gov't, P.H.S.

Consensus Development Conference

Historical Article

Research Support, N.I.H., Extramural

Editorial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Product Surveillance, Postmarketing""[mesh_terms]

141 Results

Searching titles within these results

The safety of chitosan as a pharmaceutical excipient.

Paul Baldrick

Regulatory toxicology and pharmacology : RTP 2010;56(3):290-9

Full Text

Abstract

Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease.

Kevin M Reavis, Kyle A Perry

Expert review of medical devices 2015;11(4):341-50

Full Text

Abstract

Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis.

Stephen B Freedman, Yaron Finkelstein, Maggie Rumantir, Elizabeth Uleryk

Annals of emergency medicine 2014;64(1):19-25.e6

Full Text

Abstract

Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee.

J F Rick Hammesfahr, Alan B Knopf, Todd Stitik

American journal of orthopedics (Belle Mead, N.J.) 2003;32(6):277-83

Full Text

Abstract

Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study.

Shiho Yamane, Rie Kanamori, Takeshi Seto

Advances in therapy 2021;38(9):4949-4960

Free Full Text

Abstract

Multiple data sources, the best way to gather safety information about medications.

Mitchell H Katz

JAMA internal medicine 2014;174(1):151

Full Text

Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data.

Jeffrey R Curtis, Miguel Regueiro, Huifeng Yun, Chinyu Su, Marco DiBonaventura, Nervin Lawendy, Chudy I Nduaka, Nana Koram, Joseph C Cappelleri, Gary Chan, Irene Modesto, Gary R Lichtenstein

Inflammatory bowel diseases 2022;27(9):1394-1408

Free Full Text

Abstract

A pharmacological surveillance study of the tolerability of policosanol in the elderly population.

Salome Fernández, Rosa Más, Rafael Gamez, Arquímedes Diaz, Julio Fernández, Santa Deibis Orta, José Illnait, Gladys Castańo, Sarahí Mendoza, Francisco Valdés, Estrella Alvarez

The American journal of geriatric pharmacotherapy 2005;2(4):219-29

Full Text

Abstract

Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.

Udho Thadani

Expert opinion on pharmacotherapy 2013;13(17):2555-63

Full Text

Abstract

Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study.

Noriaki Nishino, Hiroyuki Susai, Ryoichi Yamada, Kyoko Ito, Yu Matsumoto, Yuri Okuda, Teruo Hashimoto, Keitaro Yokoyama

Clinical and experimental nephrology 2022;26(7):688-699

Free Full Text

Abstract

Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies.

Olivier Bruyère, Jean-Yves Reginster, Majed Alokail, Nasser Al-Daghri, Germain Honvo, Laetitia Lengelé

Drugs 2025;85(4):505-555

Free Full Text

Abstract

Sibutramine in clinical practice.

N Finer

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;25 Suppl 4():S12-5

Full Text

Abstract

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.

Deborah Wolbrette, Mario Gonzalez, Soraya Samii, Javier Banchs, Erica Penny-Peterson, Gerald Naccarelli

Vascular health and risk management 2010;6():517-23

Free Full Text

Abstract

Safety of Ferric Citrate Hydrate in Pregnant Women With Iron Deficiency Anemia, Fetuses, and Newborns: A Real-World, Observational, Post-Marketing Surveillance Study.

Shinichiro Suzuki, Teruo Hashimoto, Yuri Okuda, Kyoko Ito, Sayaka Ito, Masahiko Shigeta, Yuki Goto, Eiji Horikawa, Noriaki Nishino, Ryoichi Yamada

The journal of obstetrics and gynaecology research 2026;52(4):e70243

Full Text

Abstract

Real-World Effectiveness and Tolerability of Tolvaptan in Patients With Heart Failure　- Final Results of the Samsca Post-Marketing Surveillance in Heart Failure (SMILE) Study.

Koichiro Kinugawa, Naoki Sato, Takayuki Inomata, Moriyoshi Yasuda, Toshiyuki Shimakawa, Yasuhiko Fukuta

Circulation journal : official journal of the Japanese Circulation Society 2020;83(7):1520-1527

Free Full Text

Abstract

Results: 1 – 15 / 141

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Product Surveillance, Postmarketing""[mesh_terms]

The safety of chitosan as a pharmaceutical excipient.

Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease.

Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis.

Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee.

Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study.

Multiple data sources, the best way to gather safety information about medications.

Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data.

A pharmacological surveillance study of the tolerability of policosanol in the elderly population.

Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.

Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study.

Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies.

Sibutramine in clinical practice.

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.

Safety of Ferric Citrate Hydrate in Pregnant Women With Iron Deficiency Anemia, Fetuses, and Newborns: A Real-World, Observational, Post-Marketing Surveillance Study.

Real-World Effectiveness and Tolerability of Tolvaptan in Patients With Heart Failure - Final Results of the Samsca Post-Marketing Surveillance in Heart Failure (SMILE) Study.

Results for

""Product Surveillance, Postmarketing""[mesh_terms]

Real-World Effectiveness and Tolerability of Tolvaptan in Patients With Heart Failure　- Final Results of the Samsca Post-Marketing Surveillance in Heart Failure (SMILE) Study.